Immvira Bioscience Files for Hong Kong IPO to Advance Oncolytic Immunotherapy Pipeline
CompanyDeals

Immvira Bioscience Files for Hong Kong IPO to Advance Oncolytic Immunotherapy Pipeline

Genevector's JWK002 Gains NMPA IND Approval for XLRS Gene Therapy
CompanyDrug

Genevector’s JWK002 Gains NMPA IND Approval for XLRS Gene Therapy

CMS Plans Secondary Listing on Singapore Exchange to Enhance Shareholder Base and Liquidity
CompanyDeals

CMS Plans Secondary Listing on Singapore Exchange to Enhance Shareholder Base and Liquidity

Livzon's YJH-012 siRNA Drug Gets NMPA Green Light for Gout Trials
CompanyDrug

Livzon’s YJH-012 siRNA Drug Gets NMPA Green Light for Gout Trials

GE Healthcare Wins FDA Approval for Vizamyl Label Update in Alzheimer’s Detection
CompanyMedical Device

GE Healthcare Wins FDA Approval for Vizamyl Label Update in Alzheimer’s Detection

NHSA Emphasizes Management of Designated Medical Institutions for Healthcare Quality
Policy / Regulatory

NHSA Emphasizes Management of Designated Medical Institutions for Healthcare Quality

Suzhou Porton Biologics Partners with Future Biotechnology to Expand Viral Vector Services
CompanyDeals

Suzhou Porton Biologics Partners with Future Biotechnology to Expand Viral Vector Services

Lundbeck's Lu AG13909 Wins Orphan Drug Designations for Congenital Adrenal Hyperplasia
CompanyDrug

Lundbeck’s Lu AG13909 Wins Orphan Drug Designations for Congenital Adrenal Hyperplasia

Henlius Biotech Doses First Patient in Japanese Bridging Trial of Serplulimab for ES-SCLC
CompanyDrug

Henlius Biotech Doses First Patient in Japanese Bridging Trial of Serplulimab for ES-SCLC

C.Q. Pharma's Prasugrel Clinical Filing Accepted by China's NMPA
CompanyDrug

C.Q. Pharma’s Prasugrel Clinical Filing Accepted by China’s NMPA

BeOne Medicines Launches Ziihera for HER2-High Biliary Tract Cancer in China
CompanyDrug

BeOne Medicines Launches Ziihera for HER2-High Biliary Tract Cancer in China

TINGSN Technology Secures RMB 100M in Series B+ Round for 4D Intracardiac Ultrasound R&D
CompanyDeals

TINGSN Technology Secures RMB 100M in Series B+ Round for 4D Intracardiac Ultrasound R&D